Mount Yale Investment Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,770
| Closed | -$201K | – | 483 |
|
|
2022
Q3 | $201K | Sell |
3,770
-48
| -1% | -$2.56K | 0.03% | 422 |
|
|
2022
Q2 | $223K | Buy |
3,818
+179
| +5% | +$10.5K | 0.03% | 417 |
|
|
2022
Q1 | $278K | Buy |
+3,639
| New | +$278K | 0.03% | 382 |
|
|
2021
Q4 | – | Sell |
-4,005
| Closed | -$224K | – | 479 |
|
|
2021
Q3 | $224K | Buy |
4,005
+17
| +0.4% | +$951 | 0.03% | 423 |
|
|
2021
Q2 | $242K | Buy |
3,988
+583
| +17% | +$35.4K | 0.03% | 370 |
|
|
2021
Q1 | $239K | Sell |
3,405
-258
| -7% | -$18.1K | 0.03% | 368 |
|
|
2020
Q4 | $219K | Buy |
+3,663
| New | +$219K | 0.03% | 362 |
|